C-24WPGameto
cell engineering, iPSC-derived technology, ovarian support cells
replacementreplacingcell therapy
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-24WP
C-24WPC-24WPcell engineering, iPSC-derived technology, ovarian support cells
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Gameto | Redefining women's health Skip to content Check Your Eligibility For Clinical Trial | Get Fertilo Updates Clinical Trial | Fertilo Updates For Patients Fertilo for Patients Is Fertilo Available in My Country Fertilo Research Study (U.S.) For Clinics Science Science Pipeline Programs Fertilo Ameno Deovo Company About Careers Partnering Publications Newsroom Contact For Patients Fertilo for Patients Is Fertilo Available in My Country Fertilo Research Study (U.S.) For Clinics Science Science Pipeline Programs Fertilo Ameno Deovo Company About Careers Partnering Publications Newsroom Cont … se by 2025, few effective treatments exist. With the help of our recent funding award through ARPA-H's Sprint for Women's Health Initiative, we believe our proprietary cell engineering will help delay the unwanted effects of menopause. Learn More Forbes "Next Generation IVF Startup" Gameto, co-founded by Under 30 alumna Dina Turner, has serious potential. Now it’s finally coming to market. Read More Endpoints News "Gameto Cleared by FDA to Test Easier IVF Process" Gameto ha … e many of the problems at the heart of the global infertility crisis. The first application of our technology, Fertilo, aims to improve the current IVF and egg freezing landscape using engineered ovarian support cells. Fertilo Our lead program. Improving outcomes for IVF and other fertility methods. More Deovo Testing and developing drugs for ovarian disease. More Ameno Making the medical burden of menopause optional. More WHAT IS FERTILO ? WHAT IS FERTILO ? IVF and Egg Freez
How Women's Health Startup Gameto Is Taking On Fertility And Menopause Subscribe Sign in 'People Thought It Was Insane': How Startup Gameto Is Turning Women's Health Sci-Fi Into Reality CEO Dina Radenkovic Turner has raised $127 million to date for a startup that's already helped with 9 births, and has bigger plans to take on menopause and ovarian health. Alex Konrad Nov 10, 2025 ∙ Paid 14 1 Share Gameto cofounder Dina Radenkovic Turner says it’s “graduation time” for her startup. Credit: Gameto The Upstart When Dina Radenkovic Turner logs extra hours for her startup, she thinks about her
Dr. Dina Turner takes us to the future - by Neel Shah, MD Subscribe Sign in Dr. Dina Turner takes us to the future A physician-turned-entrepreneur on how reprogrammed stem cells are transforming reproductive health care. Neel Shah, MD Aug 21, 2025 7 1 Share Gameto , co-founded by CEO Dr. Dina Turner, can trace their origins to donated skin cells. These cells were reprogrammed using cell engineering and turned into an indefinitely available bank of ovarian tissue—effectively a human organ in a dish. The mere fact that this is possible is enough to astonish most people. But what is even more rem … edicine seemed like the one and only profession that I could go into that would apply a little bit of everything. Subscribe to The Preprint Not all scientists can be entrepreneurs, and certainly not all entrepreneurs are scientists. And yet you are the quintessential combination of both. What made you want to move into the entrepreneurial space? I fast tracked a lot of my education and moved by myself to the United Kingdom, and then later to the United States. By being in the … ou come up with this idea. I told myself, okay if I finish my exams early, I’ll apply to Founders Forum. But then they extended the application deadline so I had no good excuse. I applied. Fast forward, I ended up as a finalist with some awards in the competition. Founders Forum is really the number one tech event in Europe, and that’s where I learned what venture capital was. I realized these entrepreneurs were just like me: they're focused on the problem. They like fast pac … , so we’ve fast forwarded a decade. By this point I’m a partner at the SALT Bio Fund, I’ve exited my first business, and I still had a research post at King’s College London at the Institute for Research in Aging. I personally became obsessed with this idea of female longevity. I was like, well, if we keep living longer and not addressing issues like infertility and later on menopause, aren’t we just worsening the root cause of gender inequality in our society? I couldn’t und … Gameto was that we would take this advancement that Shinya Yamanaka won a Nobel Prize for in 2012— induced pluripotent stem cells—and use this to make human-like ovaries in a dish. Now in our lab we have ovaries of women of different ages, and we can induce different diseases. Okay, let’s back up a bit. What are pluripotent stem cells? Basically,
Company | Gameto Skip to content Check Your Eligibility For Clinical Trial | Get Fertilo Updates Clinical Trial | Fertilo Updates For Patients Fertilo for Patients Is Fertilo Available in My Country Fertilo Research Study (U.S.) For Clinics Science Science Pipeline Programs Fertilo Ameno Deovo Company About Careers Partnering Publications Newsroom Contact For Patients Fertilo for Patients Is Fertilo Available in My Country Fertilo Research Study (U.S.) For Clinics Science Science Pipeline Programs Fertilo Ameno Deovo Company About Careers Partnering Publications Newsroom Contact Redefining wom … o. She has raised $117 million in venture funding, secured a $10 million ARPA-H award, and led the first iPSC cell therapy to reach Phase 3 clinical trials in the USA. Prior to Gameto, she was a Partner at SALT Bio Fund and held research posts at King’s College London and the Buck Institute for Research on Aging. She holds a dual degree in medicine and physiology from UCL Medical School, completed her residency at St Thomas’ Hospital London, and has authored over 46 peer-revi … is medical degree from the American University of Beirut, and has completed his Residency in Obstetrics and Gynecology from the University of Mississippi with further subspecialty training in Reproductive Endocrinology and Infertility from the University of Cincinnati in Ohio. In addition to practicing medicine, Dr. Haddad is also a prolific entrepreneur. He co-founded the Houston Fertility Institute (currently Aspire HFI) and drove it to become one of the largest fertility p … versity of Georgia Master of Laws program where she received a merit-based full scholarship. Her most recent role was in Complex Litigation at Clarin Group, where she worked on high-stakes cases, such as securing an injunction against the federal government of Argentina to suspend the nationalization of telecommunication services. Agustina has performed pro bono work, including a project funded by the United Nations Democracy Fund which aims to promote vulnerable women’s acce … ons and multiple awards, including International Society for Stem Cell Research Award for Scientific Excellence, and Rising Star Award from Massachusetts Institute of Technology. close popup Sabrina Piechota Embryology Department Manager Sabrina Piechota Embryology Department Manager Sabrina leads the embryology department at Gameto, instrumental
Gameto's $44M Series C to Help Redefine Reproductive Care, as First Patients Recruited for Pivotal Stem Cell Phase 3 Trial Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All News Releases All Public Company English-only News Releases Overview Multimedia Gal … States , a long-awaited milestone following Shinya Yamanaka receiving the Nobel Prize for iPSC technology in 2012. Gameto's novel technology is redefining reproductive care, with opportunities to shift the paradigm from IVF and egg freezing to ovarian therapeutics and delaying menopause. "This is a defining moment for Gameto and for our broader mission of advancing women's and family health," said Dr. Dina Radenkovic Turner , CEO and co-founder of Gameto. "With this fundraisi … tform Login ProfNet Data Privacy Do not sell or share my personal information : Submit via [email protected] Call Privacy toll-free: 877-297-8921 Contact PR Newswire Products About My Services All News Releases Platform Login ProfNet Call PR Newswire at 888-776-0942 Terms of Use Privacy Policy Information Security Policy Site Map RSS Cookies Copyright © 2026 Cision US Inc. --> -->
Recently, Dina Radenkovic (Turner) and Bruna Paulsen, PhD joined hosts of the Stem Cell Podcast, Daylon James and Arun Sharma to talk about what we are working on at Gameto. They discussed our cell… | Gameto LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any tim … ive medical and stem cell engineering fields, and how they ended up choosing to apply their expertise in the women’s health space. Thank you for having us on your podcast, Daylon and Arun, and for a great conversation! Listen to the full episode, “Ep. 281: “Fertility Treatments,” NOW on all major podcast platforms, or stream it from the Stem Cell Podcast website here: https://lnkd.in/eC8QtYG6 59 1 Comment Like Comment Share Copy LinkedIn Facebook X Stem Cell Podcast 1y Report
In Conversation with Dina Radenkovic Turner, Gameto’s CEO and Co-Founder | Inside Precision Medicine clinicalomicsprowebdirectory Facebook Linkedin Twitter News Topics Informatics Molecular Dx Patient Care Oncology Precision Medicine Translational Research Magazine Browse Issues Subscribe Subscribe Get Inside Precision Medicine Magazine Get Inside Precision Medicine eNewsletters Multimedia Webinars Summits Podcasts Videos Inside Precision Medicine Live Learning Labs eBooks Search Facebook Linkedin Twitter Sign in Welcome! Log into your account your username your password Forgot your password? … few years at Kings College London before moving to the U.S. She joined SALT Bio Fund as a partner in New York in 2020 while also working part-time at the Buck Institute, before going on to found Gameto in 2021. Inside Precision Medicine senior editor Helen Albert spoke to Radenkovic Turner about her inspirations, goals for Gameto, and her hopes for the future of women’s reproductive health. Q: What inspired you to get into science and medicine? Radenkovic Turner: I think grow … about, but they cause a lot of morbidity. Last year we won a $10 million ARPA-H grant, which was very competitive. There were 1,700 applicants from universities and companies all across the world, even though it was funded by the U.S. government. With our additional Series C that we’ve also closed recently, we’re hoping that we can bring the first asset from that program to the clinic. It’s a vaginal ring that is similar to some of these estrogen-based rings that we already h … term. If you only have money for the seed stage, but you know that nobody will fund the Phase II or Phase III, it doesn’t make sense to invest. There are obviously other reasons too. Some funds say, “We don’t have a woman on the company, suggesting that should be a prerequisite or suchlike.” So there’s an element of that sometimes, but we’re seeing more diversification. Most people just want to do a good job, and they want to have a return for investors. If you convince them
Instagram Instagram Log In Sign Up Close Never miss a post from gametogen Sign up for Instagram to stay in the loop. Sign up Log in gametogen and dr_dina_rad_turner More options gametogen 71w Big news for women’s health! Gameto is proud to announce FDA clearance for our Phase 3 study, set to launch at 15 sites nationwide. We’re on a mission to improve the IVF experience, making it more accessible, less invasive, and ultimately more successful for women everywhere. The full Endpoints article can be found linked in the newsroom on our website and in our Instagram story. ✨ The trial begins soon—s
Bruna Paulsen, PhD and I recently had a great conversation about the work we are doing at Gameto with the Stem Cell Podcast's Daylon James and Arun Sharma. I look forward to sharing when the episode… | Dina Turner LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices … pany recently received an Advanced Research Projects Agency for Health (ARPA-H) award for their #menopause research. Learn more: bit.ly/4dZ05go 80 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in 13,915 followers 252 Posts 6 Articles View Profile Follow More from this author Gameto's $44M Series C to Help Redefine Reproductive Care, as First Patients Recruited for Pivotal Stem Cell Phase 3 Trial Dina Turner 10mo Gameto 2024 Wrapped Dina Turner 1y
Gameto founder talks menopause and female healthspan extension Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Rokit Healthcare to begin h... … problem of fertility. So now we’re trying to use the ovaroids both for an application for maturation of eggs and fertility, and also for computational drug toxicity and discovery analysis.” Delay menopause, increase healthspan While Gameto’s initial focus is on the “established market” of fertility, Turner says the company’s ultimate mission is much broader. “Scientifically, we are already manipulating cells in vitro , so it’s easier for us to prove and test our t
Ep. 281: "Fertility Treatments" Featuring Drs. Dina Radenkovic and Bruna Paulsen - The Stem Cell Podcast Skip to main content Hit enter to search or ESC to close Search Close Search search Menu Episodes Upcoming Guests About Our Story Hosts Resources Newsletter Contact Us Share Your Feedback Listen Now search Listen Now Episodes Upcoming Guests About Our Story Hosts Resources Newsletter Contact Us Share Your Feedback Germ Cells Reproduction Ep. 281: “Fertility Treatments” Featuring Drs. Dina Radenkovic and Bruna Paulsen By kmcburney November 12, 2024 March 25th, 2026 No C
I recently had a great conversation with my little sister and clinical pharmacist, Nadia Radenkovic, on her new podcast, Nadia’s Lab. We talked about what the team is working on at Gameto and my… | Dina Turner LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any t
Instagram Instagram Log In Sign Up Close Never miss a post from gametogen Sign up for Instagram to stay in the loop. Sign up Log in gametogen and dr_dina_rad_turner More options gametogen 89w @dr_dinaradenkovic sat down with @aligorman of @biotechtvhq yesterday at the @nyse to discuss what we are currently working on at Gameto. Check out these highlights from their conversation— full interview linked in our story. Load more comments dianavgaspar 66w This makes me so happy to hear!!’ You should be so proud of yourself!!! Čestitam!! Like Reply smamr1212 67w @gametogen in which clinics in Peru do
Thank you to Ali Gorman, Brad Loncar, and BiotechTV for hosting me this morning at the NYSE to talk about our work at Gameto! | Dina Turner | 11 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join Linked
Gameto on MSNBC: Egg freezing and fertility tech | Dina Turner posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to Lin
--> --> How Gameto is reshaping women’s healthcare and making up for lost time | Insight Partners Go to home page main-logo main-logo Why Insight? Portfolio Team Ideas Events Go Login --> --> --> --> --> main-logo-solid Why Insight? Portfolio Team Ideas Events Go Login twitter linkedin instagram ©2026 Insight Partners Back Back Leadership How Gameto is reshaping women’s healthcare and making up for lost time February 11, 2026| 4 min. read --> Summary twitter facebook linkedin email Current fertility treatments take a physical, financial, and professional toll on women. The process of IVF … oth the United States and the United Kingdom before joining New York’s SALT Bio Fund as a partner in 2020. Over time, one pattern became difficult to ignore. “Women’s health biopharma as a field is very, very small and neglected, and we wanted to see better treatments that we wanted to use, that our friends, our sisters, and mothers wanted to use, and have better healthcare outcomes,” she says. The new kid in biopharma In 2020, Turner founded Gameto alongside fertility … ’s reproductive life cycle. From platform to patients Gameto’s first commercial application of its innovation platform is Fertilo , a cell-based therapy designed to mature eggs outside the body — a process known as in vitro maturation. Traditional IVF and egg-freezing usually require two weeks of hormone injections, which can come with significant side effects that affect the entire body. “Fertilo cuts down injections from two weeks to two days,” says Turner. Fertilo has unde
Joining Nasdaq to talk about Gameto and Fertilo | Dina Turner posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to Link … a miracle in size. Over 10 million babies have been born worldwide and a Nobel Prize in medicine was received for the discovery. But the female patient journey hasn't changed since the first IVF baby was born in 1978 in the UK, right? Women still today have about two weeks of twice daily hormone injections that are today still urine derived from urine of other women or recombinant hormones. So the patient journey is difficult emotionally, physically, financially. Psychologic … field of induced for potent stem cells, right? Cincinnati Yamanaka won a Nobel Prize for that in 2012. Kamito was actually, I believe the first phase three that won Ind clearance from the FDA to start a phase two trial of an IPC therapy. We were very proud to see a biomedical first, but this time happens to be in Women's Health where historically was very much lacking behind other areas of of medicine. We have so much more modern precision medicine engineering techniques. So … inics. It is the fertile cycle versus the short medical IBM and there will be a stipend towards your next cycle for patients who don't get pregnant. So that will be starting to recruit and in the United States and then for patients outside of the United States, we keep adding more and more partners and. Their actions where we are cleared, we're also under regulatory review in numerous other jurisdictions. So for international audience, again on our website, they can link to t
Gameto launches Phase III iPSC fertility trial following IND greenlight - Clinical Trials Arena Skip to site menu Skip to page content Switch language: .translate --> CT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Approvals Operations Outsourced Services Supply Chain Data Management Medical Devices Themes Artificial Intelligence Cloud Corporate Governance Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insights Deals Jobs Filings Patents Social Media Companies Company A-Z … US Food and Drug Administration (FDA) granted an investigational new drug (IND) application. US-based Gameto will now launch its multi-centre US trial to establish the efficacy of its ovarian support cell (OSC) technology designed to mature eggs outside the body using iPSC technology, in a system the company argues requires 80% fewer hormonal injections than traditional in vitro fertilisation (IVF) methods. Discover B2B Marketing That Performs Combine business intelligence an … ertilo builds on that of Japanese researcher Shinya Yamanaka, who won the Nobel Prize for Physiology and Medicine in 2012 for his discovery of iPSC. Gameto co-founder Dina Radenkovic said: “By overcoming the major challenges of conventional IVF such as long treatment cycles, significant side effects, and the emotional and physical strain, Fertilo provides a potentially faster, safer, and more accessible solution for families. This milestone marks a turning point in reproducti … milestone marks a turning point in reproductive health and highlights the first application of iPSC technology in IVF and the immense potential of our technology.” Elsewhere in the world of IVF treatment, Spanish fertility biotech Oxolife has presented positive exploratory Phase II data for its non-hormonal fertility pill. --> Sign up for our daily news round-up! Give your business an edge with our leading industry insights. Sign up Share Copy Link Share on X Share on Linkedi
Instagram Instagram Log In Sign Up Close Never miss a post from gametogen Sign up for Instagram to stay in the loop. Sign up Log in gametogen and overwaterventures More options gametogen 43w We are excited to announce that Gameto has raised a $44 million Series C financing round led by Overwater Ventures, a firm bridging breakthrough science with brand-building and next-generation business creation, with participation from Insight Partners, RA Capital, Two Sigma Ventures, BOLD Capital Partners, Future Ventures, Ingeborg Investments, Arcadia Investment Partners, PAGS Group, Pontiva Healthcare P … rial using induced pluripotent stem cells (iPSCs) since Shinya Yamanaka’s Nobel Prize in 2012, with potential to be the first ever approved iPSC product in any therapeutic area, and it’s happening in women’s health. 2️⃣ Expanding and strengthening our pipeline Following our $10 million ARPA-H award for our menopause program as part of the White House Initiative on Women’s Health Research, we’re now advancing our implant and vaginal ring for primary ovarian insufficiency (POI)
Perplexity Offers $34.5B for Google Chrome, Periodic Labs Raises $200M, & NVIDIA Becomes a Professor (For Robots) TradedVC Login Subscribe 0 TradedVC Posts Perplexity Offers $34.5B for Google Chrome, Periodic Labs Raises $200M, & NVIDIA Becomes a Professor (For Robots) Perplexity Offers $34.5B for Google Chrome, Periodic Labs Raises $200M, & NVIDIA Becomes a Professor (For Robots) Profound Lands $35M funding, Vulcan Elements $65M Series A, Gameto’s $44M Series C, here's your snapshot of the biggest tech and venture transactions shaping the market today Traded: Venture Capital Augus … e agency platform. EDGX (Ghent, Belgium) – €2.3M Seed led by imec.istart future fund with the Flanders Future Tech Fund for AI edge computers for satellites. Liquid (São Paulo, Brazil) – $2.1M seed led by SaaSholic with Flourish Ventures, Honey Island by 4UM, and Crivo Ventures for real-estate credit automation. Swirltex (Calgary, Canada) – $1.2M seed led by the Central Texas Angel Network (CTAN) for wastewater treatment tech. 🌱 Series A Periodic Labs (San Francisco, CA) – $ … igeria) – $9M Series A led by Novastar Ventures with YC, AAIC Investment, Rebel Fund, GFR Fund, Kaleo, HoaQ, and others for its on-demand delivery platform. Xpand (Tel Aviv, Israel) – $6M led by Ibex Investors and Emerge to build autonomous, AI-powered retail stores. 🌳 Series B+ & Growth Aira (Stockholm, Sweden) – €150M (~$174M) equity from Altor, Kallskär, Kinnevik, Lingotto & Temasek to scale heat-pump rollout and manufacturing. beatBread (Los Angeles, CA) – $124M … onless Capital (Miami, FL, USA) – Raising $60M for its third blockchain-focused fund; previously raised $20M. Founders: Want to be featured on @tradedvc ? → traded.co/submit/vc 📚 Read of the Day Nvidia Wants to Teach Robots How to Think Meet Cosmos Reason — AI’s Brain for the Physical World At SIGGRAPH 2025 , Nvidia dropped Cosmos Reason , a 7-billion-parameter vision-language model built to give robots something they’ve never truly had before: the ability to “reason” about … 🏛️ Intel CEO spared from removal after presidential intervention 📉 U.S. proposal to take a share of Nvidia and AMD revenue raises policy debate TradedVC Startup Feature! Apply via this form to feature your startup; it’s free. app.youform.com/forms/lptzbggt. @tradedvc posts on 🔥 tradedvc 174K followers View more on Instagram tradedvc Add
You need to enable JavaScript to run this app. Loading...
Press Releases | Gameto Skip to content Check Your Eligibility For Clinical Trial | Get Fertilo Updates Clinical Trial | Fertilo Updates For Patients Fertilo for Patients Is Fertilo Available in My Country Fertilo Research Study (U.S.) For Clinics Science Science Pipeline Programs Fertilo Ameno Deovo Company About Careers Partnering Publications Newsroom Contact For Patients Fertilo for Patients Is Fertilo Available in My Country Fertilo Research Study (U.S.) For Clinics Science Science Pipeline Programs Fertilo Ameno Deovo Company About Careers Partnering Publications Newsroom Contact Gameto
This week, Gameto presented at the JP Morgan Healthcare Conference, in front of investors, pharma companies and other healthcare innovators. Our CEO and co-founder, Dina Radenkovic Turner, took the… | Gameto LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any tim … h fertility clinic network IVF Australia of the Virtus Health Group ➡️ Our $10M award from Advanced Research Projects Agency for Health (ARPA-H) ’s Sprint for Women’s Health Initiative to accelerate the development of our menopause program We also had an engaging Q&A discussion, following the presentation, joined by Gameto’s Co-founder and Chairman, Martin Varsavsky , and our Chief Scientific Officer, Christian Kramme, PhD . We look forward to sharing more exciting update
Instagram Instagram تسجيل الدخول تسجيل إغلاق لا تفوّت منشورًا من gametogen مطلقًا يمكنك التسجيل في Instagram للبقاء على اطلاع. تسجيل تسجيل الدخول الإشارات martinvars emilybcassidy kvjordan dr_dina_rad_turner gametogen • متابعة خيارات إضافية gametogen 74 أ Gameto team members will be attending the 2025 JP Morgan Healthcare Conference in San Francisco, California this January. We would love to see you there! تحميل مزيد من التعليقات لا توجد تعليقات حتى الآن. ابدأ المحادثة. أعجبني ١٦ تعليق مشاركة حفظ 9 يناير، 2025 قم بتسجيل الدخول لتسجيل الإعجاب أو التعليق. المزيد من المنشورات من gametogen عنصر دو
Gameto to Present at 43rd Annual J.P. Morgan Healthcare Conference - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Pres … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Gameto to Present at 43rd Annual J.P. Morgan Healthcare Conference January 8, 2025 | 1 min read Twitter LinkedIn Facebook Email Print AUSTIN, Texas--(BUSINESS WIRE)-- #JPM2025 -- Gameto , a biotechnology company dedicated to advancing treatment option in women's health, today announced that Dr. Dina Raden … alac Obesity ADA: Novo boasts deep pipeline, ‘breadth of assets’ after analysts award Lilly weight loss gold June 8, 2026 · 5 min read · Heather McKenzie Obesity ADA: Boehringer leans on fat mass benefits as obesity bet delivers ‘less competitive’ weight reduction June 8, 2026 · 2 min read · Tristan Manalac BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunitie … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Instagram Instagram Log In Sign Up Close Never miss a post from gametogen Sign up for Instagram to stay in the loop. Sign up Log in gametogen • Follow More options gametogen 52w This week, Gameto team members Christian Kramme, Bruna Paulsen, and Ferran Barrachina, are attending the International Society for Stem Cell Research's 2025 Annual Meeting in Hong Kong, China. Christian and Ferran will both be presenting posters at the conference, as well as joining Fredrik Lanner to speak at the BioLamina innovation showcase. We are excited about the opportunity to engage with leaders in the stem
REPROCELL Announces License Agreement with Gameto for the Advancement of its Program to Improve Assisted Fertility using iPSCs Skip to main content REPROCELL Cell Therapy Developers Clinical‑grade stem cell and gene editing services to accelerate your translational pathway. ❯ For Cell Therapy Developers Clinical Stem Cell Services StemEdit Clinical Gene Editing Services 探索临床级 iPSC 详情 GMP iPSC & iMSC MCB Manufacturing – REPROCELL USA GMP iPSC & MSC MCB Manufacturing – Histocell (Europe) GMP Manufacturing Facility – REPROCELL Japan GMP-grade iMSC & MSC production iPSC-Derived Exosome … arn Learning Center Brochures Webinars Other Videos FAQs Case Studies Protocols Application Notes and Whitepapers Scientific Publications Scientific Posters Blog Latest on our Blog Streamlining PBMC Processing for Reliable Results in Multi-Site Clinical Trials: Key Challenges and Solutions 11 June 2026 AI-Designed CRISPR Enables Hypoimmune iPSC Engineering for Off-the-Shelf Cell Therapy 04 June 2026 What Are Off-Target Effects in Cellular Gene Editing? Ris … Japan — REPROCELL Inc. today announced that it has entered into an agreement to grant Gameto Inc., a female-led biotechnology company with a mission to redefine women’s healthcare, a non-exclusive right to use REPROCELL’s StemRNA™ Clinical Seed iPSCs. The clinical-grade iPSC line will be used for the development and commercialization of Gameto’s program to improve the IVF and egg freezing process, Fertilo. Terms of the agreement were not disclosed. Fertilo is an iPSC-derived
Gameto Licenses Foundational Meiosis IP from Harvard to Advance Human Ovary-in-a-Dish Platform - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Gameto Licenses Foundational Meiosis IP from Harvard to Advance Human Ovary-in-a-Dish Platform January 30, 2026 | 3 min read Twitter LinkedIn Facebook Email Print Newly licensed intellectual property enables genetic induction of early meiosis, further strengthening Gameto’s best-in-class platform for mode … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Gameto Licenses Foundational Meiosis IP to Advance Human Ovary-in-a-Dish Platform - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cance … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Gameto Licenses Foundational Meiosis IP to Advance Human Ovary-in-a-Dish Platform February 2, 2026 | 3 min read Twitter LinkedIn Facebook Email Print Newly licensed intellectual property developed in the Church Lab at Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering at H … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Gameto's $44M Series C to Help Redefine Reproductive Care, as First Patients Recruited for Pivotal Stem Cell Phase 3 Trial - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals B … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Gameto’s $44M Series C to Help Redefine Reproductive Care, as First Patients Recruited for Pivotal Stem Cell Phase 3 Trial August 13, 2025 | 5 min read Twitter LinkedIn Facebook Email Print As birth rates decline and US IVF access falls further behind, Gameto recruits first Phase 3 patients for cutti … States , a long-awaited milestone following Shinya Yamanaka receiving the Nobel Prize for iPSC technology in 2012. Gameto's novel technology is redefining reproductive care, with opportunities to shift the paradigm from IVF and egg freezing to ovarian therapeutics and delaying menopause. "This is a defining moment for Gameto and for our broader mission of advancing women's and family health," said Dr. Dina Radenkovic Turner , CEO and co-founder of Gameto. "With this fundraisi … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin